About QLSF Biotherapeutics
QLSF Biotherapeutics is a company based in San Francisco (United States) founded in 2016 by Hieu Van Tran. It operates as a B2B. QLSF Biotherapeutics offers products and services including QL325 CLEC12A x CD3, QL335 LY6G6D x CD3, QL301 PD-L1 x 4-1BB, QL401 PD-L1 x CD47, and QL325 PD-L1 x IL-15. QLSF Biotherapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Revolution Medicines, among others.
- Headquarter San Francisco, United States
- Founders Hieu Van Tran
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Qlsf Biotherapeutics Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of QLSF Biotherapeutics
QLSF Biotherapeutics offers a comprehensive portfolio of products and services, including QL325 CLEC12A x CD3, QL335 LY6G6D x CD3, QL301 PD-L1 x 4-1BB, QL401 PD-L1 x CD47, and QL325 PD-L1 x IL-15. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Bispecific antibody targeting acute myeloid leukemia in clinical trials.
Targets colorectal cancer through T cell engagement.
Activates T cells for treating advanced malignant tumors.
Promotes tumor cell phagocytosis in cancer therapy.
Enhances immune response against tumors in clinical stages.
Unlock access to complete
Senior Team
5 people
Co Team
1 people
Leadership Team
1 people
Principal Team
1 people
Scientist Team
1 people
Unlock access to complete
Funding Insights of QLSF Biotherapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by QLSF Biotherapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - QLSF Biotherapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Qlsf Biotherapeutics Comparisons
Competitors of QLSF Biotherapeutics
QLSF Biotherapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Revolution Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about QLSF Biotherapeutics
When was QLSF Biotherapeutics founded?
QLSF Biotherapeutics was founded in 2016.
Where is QLSF Biotherapeutics located?
QLSF Biotherapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
What does QLSF Biotherapeutics do?
QLSF Biotherapeutics is an immuno-oncology startup in South San Francisco, focusing on innovative antibody-based therapeutics for cancer. They use rational design to create modular molecules that target immune systems, including T cell engagers and bispecific antibodies. The company conducts clinical trials and partners with pharmaceutical firms like Qilu Pharmaceutical for development and research support.
Who are the top competitors of QLSF Biotherapeutics?
QLSF Biotherapeutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does QLSF Biotherapeutics offer?
QLSF Biotherapeutics offers QL325 CLEC12A x CD3, QL335 LY6G6D x CD3, QL301 PD-L1 x 4-1BB, QL401 PD-L1 x CD47, and QL325 PD-L1 x IL-15.